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ElectroporationA new class of penetrating peptides that can target the mitochondria with high speciﬁcity was recently discov-
ered. In this work, we developed amodel inner mitochondrial membrane, equippedwith a transmembrane gra-
dient, suitable for solid-state NMR experiments. Using solid-state NMR,we observed amitochondria-penetrating
peptide interacting with the model inner mitochondrial membrane to gain insight into the mechanism of trans-
location. The paramagnetic relaxation effect due to Mn2+ ions on 13C magic angle spinning NMR was used to
measure the insertion depth of the peptide and its distribution in each monolayer of the membrane. We found
that at low peptide concentration the peptide binds to the outer leaﬂet and at high concentration, it crosses
the hydrophobic bilayer core and is distributed in both leaﬂets. In both concentration regimes, the peptide
binds at the C2 position on the lipid acyl chain. Themitochondria-penetrating peptide crossed to the inner leaﬂet
of the model membranes without disrupting the lamellarity. These results provide evidence that supports the
electroporation model of translocation. We estimated the energy associated with crossing the inner mitochon-
drial membrane. We found that the transmembrane potential provides sufﬁcient energy for the peptide to
cross the hydrophobic core, which is the most unfavorable step in translocation.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
Mitochondria are an interesting target for drug delivery due to their
role in energy production, reactive oxygen species production, and ap-
optosis [1–9]. Drug delivery to the mitochondria is difﬁcult due to the
intricacies involved in crossing three diverse membranes (Fig. 1): the
plasma membrane, and the outer and inner mitochondrial membranes
(OMM and IMM, respectively) [10–13]. Overcoming these challenges, a
new class of synthetically designed peptides was recently discovered to
penetrate the plasmamembrane and target themitochondria with high
speciﬁcity, coined mitochondria-penetrating peptides (MPPs) [10]. By
targeting the mitochondria directly, MPPs become a valuable vehicle
for drug delivery. For instance, methotrexate is a powerful antibacterial
agent, but accumulation in the cytosol of human cells renders it highly
toxic and limits its therapeutic capabilities [14]. By conjugating metho-
trexate to MPPs, the drug speciﬁcally targeted the mitochondria, de-
creasing the toxicity three orders of magnitude, while maintaining
antibacterial activity [14]. However, the mechanism by which MPPs
are able to reach the mitochondrial matrix remains unknown. Due to
the resolution limit of confocal microscopy, the outer and inner mito-
chondrial membranes cannot be resolved with ﬂuorescence techniques
and it is impossible to determine whether or not the MPPs remain
bound to the inner mitochondrial membrane or cross this barrier to lo-
calize in the matrix.l rights reserved.Solid-state nuclear magnetic resonance (ssNMR) is a useful tool to
study peptide–lipid interactions with atomic scale resolution. Recent
studies have proven that ssNMR is vital to evaluate membrane interac-
tion with antimicrobial peptides [15–22], cell-penetrating peptides
[23–25], channel-forming peptides [18,26,27], and viruses [18,28–30].
Several model membrane formulations have been reported to examine
the interplay between various peptides and plasma membranes.
Recent studies have shown that membrane composition, speciﬁcally
headgroup functionality, and transmembrane potential play important
roles in membrane–peptide activity by controlling peptide binding
and subsequent bilayer disruption or alteration [18,19,31–37]. The re-
cent development of MPPs presents the need to develop an accurate
model of inner mitochondrial membranes that is well suited for
ssNMR measurements. The combination of model inner mitochondrial
membranes and ssNMR provides the platform to study the MPP effect
on the bilayer lamellarity as well as membrane insertion depth, in
order to gain insight into the mechanism of translocation.
In general, penetrating peptides are small, water soluble peptides
with many cationic and hydrophobic residues [38–40]. These peptides
are able to cross membranes in a highly efﬁcient, non-lytic fashion to
deliver cargo to the interior of cells, but themechanism of translocation
remains unknown [38–40]. Several proposed models exist to describe
the apparent energy-independent mode of membrane penetration, in-
cluding the inverse micelle model [41,42], the electroporation model
[43,44], and the guanidinum-phosphate complexation model [24], all
of which show distinct spectroscopic signatures. By utilizing static 31P
and paramagnetic relaxation enhancement (PRE) ssNMR techniques,
Fig. 1.Membrane barriers encountered by mitochondria-penetrating peptides. Cell penetrating peptides only cross the plasma membrane. Mitochondria-penetrating peptides must
cross a total of three membranes; the plasma membrane and the outer and inner mitochondrial membranes to reach the matrix.
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and peptide insertion depth, in order to differentiate between each
model.
The peptide–lipid interaction is believed to be a vital step in the
translocation. The favorable interaction between cationic peptides
and negatively charged phospholipid headgroups is thought to be
the ﬁrst step in translocation, and is shared by penetrating peptides
[18,23–25,45], antimicrobial peptides [20,21,31,46–49], and voltage
gated channel-forming peptides [26,27,50]. In the inverse micelle
model, the peptide remains bound at the membrane–water interface
throughout translocation and the formation of inverse micelles per-
mits passage to the membrane interior [41,42]. The presence of an in-
verse micelle phase produces an isotropic peak in 31P powder pattern
which is consistent with a disruption of the native lamellar character
and the rapid tumbling of micelles [51–53].
In the electroporation and guanidinium-phosphate complexation
models, the cationic peptide charge and anionic lipid charge are be-
lieved to play a role in both initial peptide–lipid interaction, as well as
the translocation mechanism. In the electroporation model, the nega-
tively charged phospholipid headgroup on the outer leaﬂet of the bilay-
er binds the cationic penetrating peptide, until the remaining anionic
surface change reaches a critical value [43]. When the peptide concen-
tration exceeds this threshold, the asymmetrically bound peptides on
the outer leaﬂet create an electric ﬁeld between the differently charged
outer and innermonolayers [43]. The transbilayer electric ﬁeld destabi-
lizes themembrane and the peptide crosses the hydrophobic core in an
electroporation-like fashion to bind to the inner leaﬂet of the bilayer
[43]. Therefore, if the peptide is internalized via the electroporation
model, we would expect to observe binding only to the outer leaﬂet at
low peptide concentrations, and binding to both the inner and outer
leaﬂets at high peptide concentrations.
The guanidinium-phosphate complexation model proposes that the
cationic arginine residues on the peptide bind electrostatically to the
anionic phosphate groups present on the lipid headgroups. By neutral-
izing the highly cationic charge, the peptides are able to cross the bilay-
er without a high free-energy penalty [24]. Since this mechanism does
not require charge accumulation to destabilize the membrane, we ex-
pect that at both high and low concentrations, the peptide will bind to
both the inner and outer leaﬂets of the bilayer [24].
To determine the mode of MPP translocation, we used 13C magic
angle spinning (MAS) PRE NMR to create a system that can distinguish
bilayer sidedness and probe peptide insertion depth, which in turn, will
differentiate between the electroporation and guanidinium-phosphatecomplexation models. To assess bilayer lamellarity during peptide in-
sertion, we used variable temperature static 31P NMR measurements.
Both static 31P and 2H NMR measurements are sensitive to alterations
in membrane integrity [20,22,53–59]. In the 13C PREmethod, paramag-
netic ions bind to membranes and cause line broadening and subse-
quent signal reduction in the NMR spectra by enhancing the T2
relaxation rate [60,61]. The PRE effect is distance dependent and can
distinguish each leaﬂet of the bilayer so the signal attenuation serves
as a spectroscopic ruler for molecular location in the membrane
[24,62,63]. The NMR relaxation enhancement due to the addition of
paramagnetic ions and tags has been exploited to provide long distance
measurements for protein structure determination [28,64–68], rapid ac-
quisition of membrane-bound protein spectra [69,70], probe protein-
biomolecule and small molecule interactions [56,71,72], distinguish be-
tween inner and outer leaﬂets of lipid bilayers [24,62,63], manipulate
bicelle orientation [73], and measure immersion depth in membrane
systems [24,74].
For our ssNMR study, we chose a peptide with high mitochondrial
localization with the amino acid sequence Cha–Arg–Cha–Lys, where
Cha = cyclohexylalanine. We constructed large unilamellar vesicles
(LUVs) with a transmembrane gradient of about−180 mV, composed
of a mixture of cardiolipin (CL, 10% mol), phosphatidylcholine (PC,
50% mol), and phosphatidylethanolamine (PE, 40% mol). We chose to
incorporate an electrochemical gradient in our model membranes be-
cause translocation of the MPPs was shown to be highly dependent on
electrochemical potential [10].We compared the spectra from three dif-
ferent peptide–lipid systems: Mn2+ free, Mn2+ bound to one side of
the vesicle, and Mn2+ bound to both the inside and outside of the ves-
icle. We were able to establish a sustainable model of inner mitochon-
drial membranes for ssNMR measurements and found that the MPP
does not alter the bilayer integrity. At low peptide concentrations, the
MPP binds to the outer leaﬂet only, whereas at high concentrations
the MPP is distributed into both leaﬂets, following the electroporation
model for translocation into the mitochondria.
2. Materials and methods
2.1. Materials
All lipid products used to form the model mitochondrial mem-
branes are commercially available, including 1,1′,2,2′-tetraoleoyl
cardiolipin sodium salt (18:1 CL), 1-palmitoyl-2-linoleoyl-sn-glycero-
3-phosphocholine (16:0–18:2 PC), and 1,2-distearoyl-sn-glycero-3-
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Polar Lipids, Inc. (Alabaster, AL). The mitochondria-penetrating peptide
(Cha–Arg–Cha–Lys) was purchased from AnaSpec, Inc. (Freemont, CA)
with uniformly labeled 13C, 15N residues at positions R2 and K4 at
>95% purity. All other chemicals were purchased from Thermo Fisher
Scientiﬁc (Pittsburgh, PA) and used as received.
2.2. Model mitochondria membrane sample preparation
We constructed large unilamellar vesicles (LUVs) that exhibited a
transmembrane gradient according to two known protocols [75,76]. A
pH difference was used to establish a transmembrane gradient. The
membrane encapsulated 300 mMpH4phosphate buffer inside the ves-
icle and 10 mM pH 7 phosphate buffer outside to establish an electro-
chemical potential of −177 mV, which is reﬂective of the biologically
encountered mitochondrial gradient of −180 mV. The existence of a
three unit pH gradient in our systemwas conﬁrmed by the ﬂuorescence
response of 9-aminoacridine as previously described [77].
Hydrated CL/PC/PE membranes were formed by dissolving the
lipids in a 95:5 benzene:ethanol mixture at an appropriate molar
ratio of 0.1/0.5/0.4, respectively. The lipid mixture was lyophilized
overnight. The dried lipid cake was rehydrated with 300 mM phos-
phate buffer at pH 4 which was heated to 85 °C. The rehydrated
lipid sample was incubated for 2 h at 85 °C and vortexed periodically
to produce multilamellar vesicles (MLVs). The resulting MLVs were
down-sized using a mini extruder (Avanti Polar Lipids, Inc.) and
passed through a 100 nm polycarbonate membrane 21 times to con-
sistently produce LUVs of uniform diameter of 100 nm. The size of the
vesicles was conﬁrmed by dynamic light scattering on a ZetaPALS
particle size analyzer. The LUVs were dialyzed for at least 8 h using
a Slide-A-Lyzer (Thermo Fisher Scientiﬁc) to remove the low pH,
high salt buffer and replace it with 10 mM phosphate buffer at pH 7
for the exterior membrane environment.
After dialysis, the MPP was added at the appropriate molar ratio
(P:L = 1:10 or P:L = 1:40) to the LUVs and incubated overnight. The
MPP–lipid mixture was centrifuged at 160,000 g for 1.5 h to yield a hy-
drated pellet, whichwas packed into a 200 μL MAS rotor. For theMn2+
containing samples, theMn2+ solutionwas prepared fromMnCl2·4H2O
and added at 8 mol% of the lipids. To obtain one side Mn2+ bound ves-
icles, the Mn2+ solution was either added after ultracentrifugation or
during extrusion, producing outside-bound and inside-bound one side
Mn2+ bound samples. For two side Mn2+ bound vesicles, the vesicles
were extruded with the appropriate percentage of Mn2+ and had
Mn2+ added after dialysis to replace the ions lost during this process.
2.3. NMR spectroscopy
All NMR measurements were performed on a Bruker Avance 500
(11.7 T) spectrometer operating at a resonant frequency of 500 MHz forFig. 2. The peptide does not dramatically alter the structure of the membrane. Static 31P NMR
there is no change in the chemical shift anisotropy of the lipid headgroups, there is no rem
micelle mechanism to be ruled out.1H, 202 MHz for 31P, and 125 MHz for 13C, equipped with a BCU05 Vari-
able Temperature Control Unit. Data was processed using Bruker Topspin
1.3 or iNMR software. All experiments were performed using a Bruker
HXY broadband MAS probehead doubly tuned to 1H/13C/Y or 1H/31P/Y.
13C chemical shifts were externally referenced to adamantane at
38.5 ppm on the TMS scale. 31P chemical shifts were referenced to 85%
phosphoric acid at 0.0 ppm. 15N chemical shifts were referenced to gly-
cine at 109.4 ppm. The spinning rate for all MAS experiments was 5
kHz and each experimentwas performed at 310 K, unless otherwise indi-
cated. 13C direct polarization (DP) MAS NMR spectra were decoupled
with two pulse phase modulation (TPPM) at 1H ﬁeld strengths of
30 kHz. Typical radiofrequency (rf) pulse lengths were ~5 μs for 13C and
~2 μs for 1H. Static 31P spectra were decoupled with WALTZ-16 at 1H
ﬁeld strengths of 6 kHz. Typical rf pulse lengths were ~4 μs for 31P.
3. Results and discussion
Static 31P chemical shift anisotropy NMR measurements were
conducted at variable temperatures (280 K–360 K) to determine if
any changes in membrane morphology or lipid transition tempera-
tures occurred upon peptide binding. The 31P NMR spectra of the
model mitochondrial membranes alone (Fig. 2a) were recorded to
provide a comparison to the peptide-bound membranes (Fig. 2b).
The observed static 31P NMR lineshape is consistent with hydrated
100 nm unilamellar vesicles, as is the observed linewidth (~2 kHz),
even at the highest temperature of 360 K [78]. The alterations in 31P
lineshape at each temperature are a reﬂection of the unique transition
temperatures for each of the lipids, ranging from 264 K for PC to
347 K for PE, and the resulting mixed liquid crystalline and gel
phases. For the peptide-containing samples, the MPP was added at a
peptide to lipid ratio of P:L = 1:12.5. This peptide concentration is
sufﬁciently high to observe membrane defects, if they are present
upon binding. No signiﬁcant remodeling of the lipid bilayer was ob-
served at any temperature, indicating that peptide insertion did not
disrupt the lamellarity of the bilayer. This observation is consistent
with the non-lytic nature of other penetrating peptides [38,79–81].
Furthermore, no isotropic peak was observed, ruling out the possibil-
ity of the formation of inverse micelles to internalize the peptide.
To assess the remaining two mechanisms of translocation
(electroporation and guanidinium-phosphate complexation), we
used a 13C MAS NMR PRE method at 310 K [24]. In order to assure
we could achieve asymmetric distribution of Mn2+ paramagnetic
ions with our new model inner mitochondrial membranes, we ﬁrst
monitored the ion position with the 31P NMR signal of the lipid
headgroups (Fig. 3). Without paramagnetic ions present, we mea-
sured the entire signal from all the phospholipid headgroups. The ad-
dition of Mn2+ to the outside of the vesicles caused signal attenuation
of about half the lipids, corresponding to dephasing of the outer leaf-
let. When the paramagnetic ions are on both sides of the bilayer, thespectra of liposomes (a) in the absence of MPP and (b) in the presence of MPP. Because
odeling of the bilayer morphology. The absence of an isotropic peak allows the inverse
Fig. 3. Mn2+ ions do not cross the bilayer and form stable one side bound samples.
Static 31P NMR spectra of (a) unbound, (b) one side Mn2+ bound with 47% dephasing,
and (c) two side Mn2+ bound with 100% dephasing CL/PC/PE LUVs.
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proximity to Mn2+. This experiment showed that Mn2+ ions bind
to lipid headgroups, but do not diffuse through the model inner mito-
chondrial membranes, even in the presence of a negative transmem-
brane gradient, allowing asymmetric Mn2+ distribution to probe
insertion depth and determine bilayer sidedness, consistent with pre-
viously reported spectra in the absence of a transmembrane gradient
[24]. Since the addition of paramagnetic ions to the system may per-
turb the electrostatic interactions in subsequent membrane–peptide
experiments, we added the minimal amount of Mn2+ to achieve suit-
able signal attenuation, at 8 mol% of the lipid concentration. The pep-
tide afﬁnity for the membrane should not be affected by this minimal
anionic phosphate charge neutralization of 8 mol%.
In order to determine whether peptide insertion is concentration
dependent, the MPP was added to the membranes at two different
peptide concentrations. Fig. 4 shows the 13C DP-MAS NMR results of
the PRE effect of one and two side Mn2+ bound membranes at both
peptide concentrations. The lipid peaks are attenuated as expected
in all samples. In the one side Mn2+ bound sample at P:L = 1:10,
the peptide peaks retain much of the signal intensity (~75%) when
compared to the unbound sample. However, in the two side Mn2+
bound spectra, much of the peptide peak intensity is dephased, withFig. 4. 13C MAS NMR spectra illustrating the attenuation due to the PRE effect at low (P:L =
the peptide location and PRE effect felt by the peptide:lipid system in one side Mn2+ bound
the unbound spectra (black) with the fraction of dephasing displayed for the peptide peaksignal retention dropping to about 50%, on average. This is consistent
with the MPP partitioning into both leaﬂets of the bilayer at high
concentration.
Fig. 5 shows a graphical representation of the PRE effect on
the normalized signal intensity for both low (P:L = 1:40) and high
(P:L = 1:10) peptide concentrations. In order to compare between
different samples, the NMR signal peak intensity was double-
normalized, (S / S0) / (S / S0)max, where S is the signal of the Mn2+
bound sample, S0 is the Mn2+ free sample, and (S / S0)max is the nor-
malized value of the lipid peak with the least attenuation. The error
bars were obtained via error propagation of the signal to noise ratio
of each peak. At low P:L = 1:40, there is no change in signal intensity
when comparing one side and two side Mn2+ bound membranes
(Fig. 4), placing the peptide solely in the outer leaﬂet. At high P:L =
1:10, the peptide retains much of its signal intensity in the one side
Mn2+ bound sample, while in the two side Mn2+ bound sample, the
signal intensity is signiﬁcantly lowered. Therefore, we can conclude
that at lowpeptide concentrations, theMPP binds only to the outer leaf-
let while at high peptide concentrations the MPP is distributed in both
the inner and outer leaﬂets of the bilayer.
Due to the low signal to noise ratio, and subsequent large error bars
for the P:L = 1:40 sample, we wanted to conﬁrm that the peptide was
only bound to the outer leaﬂet of the bilayer. To achieve higher resolu-
tion spectra to support this claim, we constructed vesicles with Mn2+
bound only to the inside of the vesicles with a P:L = 1:40 and com-
pared the normalized signal intensities to P:L = 1:40 with no Mn2+,
and P:L = 1:40 with Mn2+ bound only to the outside of the vesicles
(Fig. 6). If the peptide was bound to the outer leaﬂet of the vesicle,
Mn2+ ions on the inner leaﬂet only should have no effect of the peptide
signal intensities, and that is what we observe. Fig. 6 shows that the
peptide signal intensity is retained for the Mn2+ inside sample. As
expected, the lipid Cγ peak intensity is the same for both the inside
Mn2+ bound and outside Mn2+ bound samples. We also constructed
the same vesicles to examine the P:L = 1:10 sample. Nearly the same
signal dephasing is observed for both one-sided Mn2+ bound samples
(inside and outside), conﬁrming that the peptide is distributed into
both the inner and outer leaﬂets, at approximately a 50/50 ratio.
We also used the 13C MAS PRE data as a spectroscopic ruler to es-
timate the MPP location in the bilayer. Since the depth associated
with the lipid peaks is known from the bilayer structure of the vesi-
cles, the signal dephasing of the peptide can be compared to that of
the lipids to estimate insertion depth. Fig. 7 shows that at P:L =
1:40, the MPP is inserted at approximately C1–C2, at the top of the
acyl chain, in the interfacial region. Due to the larger error associated1:40) and high (P:L = 1:10) peptide concentration. The membrane schematics indicate
(top) and two side Mn2+ bound samples. All attenuated spectra (red) are overlaid with
s.
Fig. 5. High peptide concentration leads to distribution in both leaﬂets. At low P:L =
1:40 the MPP only binds to the outer leaﬂet because there is no change in the signal
intensity. At high P:L = 1:10 the one side Mn2+ bound sample shows high signal in-
tensity and the two side Mn2+ bound sample shows low signal intensity, indicative
of distribution in both leaﬂets.
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peptide may be closer to the surface of the bilayer than the high con-
centration sample, and the signal dephasing serves only as an approx-
imation for insertion depth. Even slight differences in insertion depth
can result in larger signal dephasing since the spin–spin relaxation
rate in the presence of paramagnetic ions is proportional to r−6,
where r is the distance between the paramagnetic center and the ob-
served resonance.
When the ratio is increased to P:L = 1:10, the peptide is distribut-
ed into both leaﬂets. Assuming that half of the peptide is bound to the
outer leaﬂet, and half is bound to the inner leaﬂet, Fig. 7b–c shows
that the MPP is inserted into both leaﬂets at C2. The peptide interac-
tion at the top of the acyl chain, near C1 (P:L = 1:40) and C2 (P:L =Fig. 6. At P:L = 1:40, the peptide is only bound to the outer leaﬂet of the vesicle, as determ
the peptide peaks retain their signal intensity with Mn2+ bound only to the inside of the v
bound to the outer leaﬂet. P:L = 1:40 in the absence of Mn2+ (black) and Mn2+ bound to
performed for P:L = 1:10. The same signal dephasing is observed whether the one-side Mn
evenly in both leaﬂets.1:10), indicates stability at this position on the lipid acyl chain, likely
due to the close proximity of the cationic peptide to the phospholipid
headgroup.
In order to estimate the insertion depth, it was assumed that the
peptides are membrane-bound, and not exchanging with the solvent.
In the rapid exchange regime, it is possible to estimate the mole frac-
tion of peptide bound by varying the peptide to lipid ratio, and mea-
suring the change in 13C chemical shift as the peptide concentration
increases [82]. No change in 13C chemical shift was observed between
P:L = 1:40 and P:L = 1:10 for the peptide resonances, indicating
that at both concentrations, the peptide is membrane-bound. This ob-
servation is consistent with previous studies on short peptides recon-
stituted in model lipid systems that found that over 90% of the
peptides were membrane bound [83,84].
From this information, we found that the concentration-dependent
peptide distribution in the inner and outer leaﬂets of the bilayer sup-
ports the electroporation model of translocation. Once bound to the
inner leaﬂet of the bilayer, the peptides can proceed to enter thematrix.
The electroporation model provides an explanation as to how and why
MPPs translocate through the dense, hydrophobic portion of the
inner mitochondrial membrane. The threshold for a sufﬁcient voltage
to form pores of electroporation ranges from−250 to−550 mV [44].
In our model membranes, we created a transmembrane gradient of
−180 mV that is equivalent to mitochondrial gradients encountered
in biological systems. While this gradient alone is not enough to form
transient pores, the accumulation of cationic peptides in the outer leaf-
let can induce an additional potential.
In the case of MPPs interacting with our model membranes, the
electrostatic potential of a few peptides binding to the outer leaﬂet
is not strong enough for electroporation because the charge is re-
duced by counterions on the phosphate headgroups [44]. In particu-
lar, PC and PE are both zwitterionic lipids, whereas CL is anionic,
with two negatively charged phosphate headgroups. In this case,ined by 13C MAS PRE NMR. The blue spectra show that within the signal-to noise error,
esicle, demonstrating that the paramagnetic ions have no effect on the peptide that is
the outside of the vesicle (red) are shown for comparison. The same experiment was
2+ ions are inside or outside of the vesicles, conﬁrming that the peptide is distributed
Fig. 7. At both high and low peptide concentrations, the MPP is bound near C2 of the lipid acyl chain. The intensity of the Mn2+ bound sample (S) double normalized with respect to
the unbound sample (S0) and the maximum lipid peak (S / S0)max. The shaded region shows the depth of MPP insertion in the bilayer for (a) two side Mn2+ with P:L = 1:40,
(b) one side Mn2+ with P:L = 1:10, and (c) two side Mn2+ with P:L = 1: 10.
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are present at a 1:1 ratio with the negative charges on the cardiolipin
headgroup. Given that the concentration of CL in our model mem-
branes is 10%, to reﬂect the occurrence in mammalian mitochondria,
peptide-to-lipid ratio of 1:40 would not fully neutralize the anionic
charge in the outer leaﬂet, assuming an even distribution of anionic
charge in both monolayers. Once an adequate amount of MPPs, the
threshold concentration, also bind, the peptides provide enough sur-
face charge density to attract additional anionic lipids in the inner
leaﬂet to provide sufﬁcient voltage to permit passage through the for-
mation of transient pores [44]. At a concentration of 1:10, the anionic
character of the outer leaﬂet is fully saturated with cationic peptides,
leading to an electroporation-like transfer of peptides to the inner
leaﬂet, as revealed in the 13C PRE NMR spectra. The concentration
dependence of translocation observed here is consistent with the
electroporation model for internalization. The MPP is able to cross
the high energy barrier of the hydrophobic bilayer core, in spite of
membrane curvature, which can play a role in preventing penetrating-
peptide translocation [85], and is likely stabilized by cardiolipin [86,87].
The inﬂuence of electrostatic interaction between anionic phospho-
lipids and cationic cell-penetrating peptides has been well-studied.
While hydrophobic interactions between the bilayer core and hydropho-
bic peptide residues were found to contribute to peptide translocation[88], several studies have found that the electrostatic attraction be-
tween negatively charged lipids and positively charged residues domi-
nates the initial binding event [23,25,88–95]. There is substantial
evidence that the anionic phospholipid electrostatic contribution
can be a minor compared to the total lipid population and still have
an effect on penetrating-peptide binding and structural reorganization
[89,91,92]. Furthermore, the anionic phospholipid–cationic peptide in-
teraction is stronger for Arg residues than Lys residues, indicating the
necessity of Arg residues to facilitate membrane insertion, especially
into the plasma membrane [94].
For MPPs, the presence of Arg clusters has been shown to increase
transport across the plasma membrane, but resulted in a decrease in
mitochondrial localization [10]. Therefore, the requirement for mito-
chondrial membrane penetration is likely different than that of the
plasma membrane, which is probably a delicate balance between
electrostatic and hydrophobic interactions between the bilayer, pep-
tides, and electrochemical gradient.
Similar NMR measurements were performed previously on a well
known cell-penetrating peptide, penetratin [24]. The translocation of
penetratinwas examined in lipid vesicleswithout a transmembrane gra-
dient and that contained ~50% anionic character. Penetratin has seven
cationic residues, and at both high (P:L = 1:10) and low (P:L = 1:40)
concentrations, it was shown to be distributed into both leaﬂets of the
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never become fully neutralized. This mechanism of internalization was
attributed to a guanidinium-phosphate complexation that allowed the
peptide to cross the hydrophobic portion of the bilayer without a high
free-energy penalty, differing from the previously proposed models
[24]. The inner mitochondrial membranes presented here should allow
easier translocation, due to the presence of a transmembrane gradient,
as well as a lower anionic content, that would become saturated more
quickly. Yet, we observe a concentration dependent mode of transloca-
tion, consistent with the electroporation model. This evidence suggests
that different classes of penetrating peptides proceed with internaliza-
tion via different mechanisms which may be lipid membrane and trans-
membrane gradient dependent.
Previous studies have implicated the importance of a transmem-
brane gradient to penetrating-peptide internalization [96–98], and
since transmembrane potential was shown to be equally important
for MPPs [10], we were motivated to create model membranes that
exhibited a electrochemical gradient. To examine the inﬂuence of a
transmembrane gradient on our system, we considered the energy
barriers the MPP had to overcome in order to go from the outer leaf-
let, through the hydrophobic center of the bilayer, to the inner leaﬂet
of the bilayer (Fig. 8). The energy cost of each step was estimated
using the Wimley–White interfacial hydrophobicity scale determined
from measurements of short peptides partitioning into zwitterionic
phosphatidylcholine (POPC) vesicles and n-octanol [99–101]. For
our system, we estimated a favorable, negative free energy change
for insertion into the interfacial region. The MPP then has to over-
come an unfavorable, positive energy barrier to cross the bilayer
core. Then, the peptide can fall back into the favorable interfacial re-
gion of the inner leaﬂet.
If we examine the force across the plasmamembrane, F = 12 kJ/mol
(assuming the membrane potential is−60 mV), this is sufﬁcient to pull
the cationic peptide across the free energy barrier in the hydrocarbon
core and overcome the stabilizing forces present in the interfacial region
to enter the cytosol. The OMM contains pore-like structures called
porins, which allow the passage of small peptides [11]. Here, the peptide
can electrostatically interact with the anionic IMM. Because the IMM is
anionic, rather than zwitterionic, the favorable free energy associated
with the water–membrane interface will be lower than the calculated
values (dotted red lines in Fig. 8). The IMM exhibits a transmembrane
potential of −180 mV, providing a force of 36 kJ/mol. Assuming the
transmembrane gradient is the only force acting on the peptide, if it is
enough to pull the peptide over the high free energy barrier of the bilayer
core (we see distribution in both leaﬂets at high peptide concentration),Fig. 8. The energy proﬁle associated with inserting the MPP into a plasma membrane
(black) and the inner mitochondrial membrane (red). The MPP is inserted into the in-
terfacial region of the outer leaﬂet. The MPP crosses a free energy barrier to reach the
hydrocarbon core of the bilayer. The MPP inserts into the interfacial region of the inner
leaﬂet, where it can be released. The transmembrane potentials provide a driving force
for translocation.it should be enough to move the peptide from the interfacial region to
thematrix, unless the peptide–lipid interaction provides enough stability
to lock theMPP in the interfacial region.While it has been indicated that
only a small percentage of peptides with similar amino acid sequences,
SS tetrapeptides [102], reach the matrix, recent studies on several
MPPs are consistentwithmatrix localization [103], suggesting these pep-
tides undergo full internalization.
4. Conclusions
We successfully constructed model inner mitochondrial mem-
branes, exhibiting a transmembrane gradient of −180 mV that were
suitable to study peptide–lipid interactions with ssNMR. The inner mi-
tochondrial membranes were used to gain insight into the mechanism
of translocation of a mitochondria-penetrating peptide. By using vari-
able temperature static 31P NMR spectroscopy, we were able to deter-
mine that the peptide did not disrupt the lamellarity of the bilayer,
nor did it affect the phase transition temperatures. We established
that themembranes were also conducive to perform asymmetric inser-
tion depth measurements, due to their non-permeable nature with re-
spect to Mn2+ ions, using 13C MAS PRE experiments. At low peptide
concentrations, the MPP binds only to the outer leaﬂet of the bilayer,
at C2 near the top of the lipid acyl chain. As the concentration is in-
creased, the peptide passes through the hydrophobic core of the
membrane and redistributes into both leaﬂets of the bilayer. These
measurements provide evidence that the MPP in this paper follows
the electroporation model for translocation.
Acknowledgements
This work was funded by NSF Career Award 0847417.
References
[1] C.A. Bradham, T. Qian, K. Streetz, C. Trautwein, D.A. Brenner, J.J. Lemasters, The
mitochondrial permeability transition is required for tumor necrosis factor
alpha-mediated apoptosis and cytochrome c release, Mol. Cell. Biol. 18 (1998)
6353–6364.
[2] M. Corral-Debrinski, J.M. Shoffner, M.T. Lott, D.C. Wallace, Association of mito-
chondrial DNA damage with aging and coronary atherosclerotic heart disease,
Mutation Research/DNAging 275 (1992) 169–180.
[3] R. Ferrari, The role of mitochondria in ischemic heart disease, J. Cardiovasc.
Pharmacol. 28 (1996) 1–10.
[4] V. Goossens, J. Grooten, K. De Vos, W. Fiers, Direct evidence for tumor necrosis
factor-induced mitochondrial reactive oxygen intermediates and their involve-
ment in cytotoxicity, Proc. Natl. Acad. Sci. U.S.A. 92 (1995) 8115–8119.
[5] R.P. Hafner, M.J. Leake, M.D. Brand, Hypothyroidism in rats decreases mitochon-
drial inner membrane cation permeability, FEBS Lett. 248 (1989) 175–178.
[6] A.T. Hoye, J.E. Davoren, P. Wipf, M.P. Fink, V.E. Kagan, Targeting mitochondria,
Accounts of Chemical Research 41 (2008) 87–97.
[7] E.J. Lesnefsky, S. Moghaddas, B. Tandler, J. Kerner, C.L. Hoppel, Mitochondrial
dysfunction in cardiac disease: ischemia–reperfusion, aging, and heart failure,
J. Mol. Cell. Cardiol. 33 (2001) 1065–1089.
[8] G. Paradies, G. Petrosillo, F.M. Ruggiero, Cardiolipin-dependent decrease of cyto-
chrome c oxidase activity in heart mitochondria from hypothyroid rats,
Biochimica et Biophysica Acta (BBA) — Bioenergetics 1319 (1997) 5–8.
[9] S.G. Pavlakis, P.C. Phillips, S. DiMauro, D.C. De Vivo, L.P. Rowland, Mitochondrial
myopathy, encephalopathy, lactic acidosis, and strokelike episodes: a distinctive
clinical syndrome, Ann. Neurol. 16 (1984) 481–488.
[10] K.L. Horton, K.M. Stewart, S.B. Fonseca, Q. Guo, S.O. Kelley,Mitochondria-penetrating
peptides, Chem. Biol. 15 (2008) 375–382.
[11] I.E. Schefﬂer, Mitochondria, John Wiley & Sons, Inc., Hoboken, New Jersey, 2008.
[12] L.F. Yousif, K.M. Stewart, K.L. Horton, S.O. Kelley,Mitochondria-penetrating peptides:
sequence effects and model cargo transport, Chembiochem 10 (2009) 2081–2088.
[13] L.F. Yousif, K.M. Stewart, S.O. Kelley, Targetingmitochondriawith organelle-speciﬁc
compounds: strategies and applications, Chembiochem 10 (2009) 1939–1950.
[14] M.P. Pereira, S.O. Kelley, Maximizing the therapeutic window of an antimicrobi-
al drug by imparting mitochondrial sequestration in human cells, J. Am. Chem.
Soc. 133 (2011) 3260–3263.
[15] L.B. Andreas, M.T. Eddy, R.M. Pielak, J. Chou, R.G. Grifﬁn, Magic angle spinning
NMR investigation of inﬂuenza A M218–60: support for an allosteric mechanism
of inhibition, J. Am. Chem. Soc. 132 (2010) 10958–10960.
[16] B. Bechinger, E.S. Salnikov, The membrane interactions of antimicrobial peptides
revealed by solid-stateNMR spectroscopy, Chem. Phys. Lipids 165 (2012) 282–301.
[17] M. Hong, Oligomeric structure, dynamics, and orientation of membrane proteins
from solid-state NMR, Structure 14 (2006) 1731–1740.
1681L.E. Marbella et al. / Biochimica et Biophysica Acta 1828 (2013) 1674–1682[18] M. Hong, Y. Su, Structure and dynamics of cationic membrane peptides and pro-
teins: insights from solid-state NMR, Protein Sci. 20 (2011) 641–655.
[19] M. Hong, Y. Zhang, F. Hu, Membrane protein structure and dynamics from NMR
spectroscopy, Annu. Rev. Phys. Chem. 63 (2012) 1–24.
[20] E.F. Palermo, D.-K. Lee, A. Ramamoorthy, K. Kuroda, Role of cationic group struc-
ture in membrane binding and disruption by amphiphilic copolymers, J. Phys.
Chem. B 115 (2010) 366–375.
[21] A. Ramamoorthy, Beyond NMR spectra of antimicrobial peptides: dynamical
images at atomic resolution and functional insights, Solid State Nucl. Magn.
Reson. 35 (2009) 201–207.
[22] E.S. Salnikov, A.J. Mason, B. Bechinger, Membrane order perturbation in the
presence of antimicrobial peptides by 2H solid-state NMR spectroscopy,
Biochimie 91 (2009) 734–743.
[23] Y. Su, T. Doherty, A.J. Waring, P. Ruchala, M. Hong, Roles of arginine and lysine
residues in the translocation of a cell-penetrating peptide from 13C, 31P, and
19F solid-state NMR, Biochemistry 48 (2009) 4587–4595.
[24] Y. Su, R. Mani, M. Hong, Asymmetric insertion of membrane proteins in lipid
bilayers by solid-state NMR paramagnetic relaxation enhancement: a cell-
penetrating peptide example, J. Am. Chem. Soc. 130 (2008) 8856–8864.
[25] Y. Su, A.J. Waring, P. Ruchala, M. Hong, Membrane-bound dynamic structure of
an arginine-rich cell-penetrating peptide, the protein transduction domain of
HIV TAT, from solid-state NMR, Biochemistry 49 (2010) 6009–6020.
[26] T. Doherty, Y. Su, M. Hong, High-resolution orientation and depth of insertion of
the voltage-sensing S4 helix of a potassium channel in lipid bilayers, J. Mol. Biol.
401 (2010) 642–652.
[27] S. Unnerståle, F. Madani, A. Gräslund, L. Mäler, Membrane-perturbing properties
of two Arg-rich paddle domains from voltage-gated sensors in the KvAP and
HsapBK K+ channels, Biochemistry 51 (2012) 3982–3992.
[28] Y. Su, F. Hu, M. Hong, Paramagnetic Cu(II) for probing membrane protein struc-
ture and function: inhibition mechanism of the inﬂuenza M2 proton channel,
J. Am. Chem. Soc. 134 (2012) 8693–8702.
[29] E. Teissier, G. Zandomeneghi, A. Loquet, D. Lavillette, J.-P. Lavergne, R.
Montserret, F.-L. Cosset, A. Böckmann, B.H. Meier, F. Penin, E.-I. Pécheur, Mech-
anism of inhibition of enveloped virus membrane fusion by the antiviral drug
arbidol, PLoS One 6 (2011) e15874.
[30] S.J. Opella, S.H. Park, S. Lee, D. Jones, A. Nevzorov, M. Mesleh, A. Mrse, F.M.
Marassi, M. Oblatt-Montal, M. Montal, K. Strebel, S. Bour, Structure and function
of Vpu from HIV-1, in: W. Fischer (Ed.), Viral Membrane Proteins: Structure,
Function, and Drug Design, 1, Springer, US, 2005, pp. 147–163.
[31] R.F. Epand, L. Maloy, A. Ramamoorthy, R.M. Epand, Amphipathic helical cationic
antimicrobial peptides promote rapid formation of crystalline states in the
presence of phosphatidylglycerol: lipid clustering in anionic membranes, Biophys.
J. 98 (2010) 2564–2573.
[32] E.F. Haney, S. Nathoo, H.J. Vogel, E.J. Prenner, Induction of non-lamellar lipid
phases by antimicrobial peptides: a potential link to mode of action, Chem.
Phys. Lipids 163 (2010) 82–93.
[33] A. Lamazière, C. Wolf, O. Lambert, G. Chassaing, G. Trugnan, J. Ayala-Sanmartin,
The homeodomain derived peptide penetratin induces curvature of ﬂuid mem-
brane domains, PLoS One 3 (2008) e1938.
[34] M.F.M. Sciacca, J.R. Brender, D.-K. Lee, A. Ramamoorthy, Phosphatidylethanolamine
enhances amyloid ﬁber-dependent membrane fragmentation, Biochemistry 51
(2012) 7676–7684.
[35] J.B. Rothbard, T.C. Jessop, R.S. Lewis, B.A.Murray, P.A.Wender, Role ofmembrane po-
tential and hydrogen bonding in the mechanism of translocation of guanidinium-
rich peptides into cells, J. Am. Chem. Soc. 126 (2004) 9506–9507.
[36] J.T.J. Cheng, J.D. Hale, M. Elliot, R.E.W. Hancock, S.K. Straus, Effect of membrane
composition on antimicrobial peptides aurein 2.2 and 2.3 from australian south-
ern bell frogs, Biophys. J. 96 (2009) 552–565.
[37] Y. Shai, Mechanism of the binding, insertion and destabilization of phospholipid bi-
layer membranes by α-helical antimicrobial and cell non-selective membrane-
lytic peptides, Biochimica et Biophysica Acta (BBA) - Biomembranes 1462 (1999)
55–70.
[38] U. Langel, The Handbook of Cell-Penetrating Peptides, CRC Press Taylor & Francis
Group, Boca Raton, FL, 2006.
[39] M. Lindgren, M. Hällbrink, A. Prochiantz, Ü. Langel, Cell-penetrating peptides,
Trends Pharmacol. Sci. 21 (2000) 99–103.
[40] J.P. Richard, K. Melikov, E. Vives, C. Ramos, B. Verbeure, M.J. Gait, L.V.
Chernomordik, B. Lebleu, Cell-penetrating peptides — a reevaluation of the
mechanism of cellular uptake, J. Biol. Chem. 278 (2003) 585–590.
[41] D. Derossi, G. Chassaing, A. Prochiantz, Trojan peptides: the penetratin system
for intracellular delivery, Trends Cell Biol. 8 (1998) 84–87.
[42] A. Prochiantz, Getting hydrophilic compounds into cells: lessons from
homeopeptides, Curr. Opin. Neurobiol. 6 (1996) 629–634.
[43] H. Binder, G. Lindblom, Charge-dependent translocation of the Trojan peptide
penetratin across lipid membranes, Biophys. J. 85 (2003) 982–995.
[44] K. Cahill, Cell-penetrating peptides, electroporation and drug delivery, IET Syst.
Biol. 4 (2010) 367–378.
[45] L. Mäler, A. Gräslund, NMR studies of three-dimensional structure and position-
ing of CPPs in membrane model systems, in, vol. 683, pp. 57-67.
[46] M. Tang, A.J. Waring, M. Hong, Phosphate-mediated arginine insertion into lipid
membranes and pore formation by a cationic membrane peptide from
solid-state NMR, J. Am. Chem. Soc. 129 (2007) 11438–11446.
[47] J.-X. Lu, K. Damodaran, J. Blazyk, G.A. Lorigan, Solid-state nuclear magnetic
resonance relaxation studies of the interaction mechanism of antimicrobial
peptides with phospholipid bilayer membranes, Biochemistry 44 (2005)
10208–10217.[48] J.D. Gehman, F. Luc, K. Hall, T.-H. Lee, M.P. Boland, T.L. Pukala, J.H. Bowie, M.-I.
Aguilar, F. Separovic, Effect of antimicrobial peptides from australian tree frogs
on anionic phospholipid membranes, Biochemistry 47 (2008) 8557–8565.
[49] L.T. Nguyen, E.F. Haney, H.J. Vogel, The expanding scope of antimicrobial peptide
structures and their modes of action, Trends Biotechnol. 29 (2011) 464–472.
[50] Z. Liu, H.J. Vogel, Structural basis for the regulation of L-type voltage-gated cal-
cium channels: interactions between the N-terminal cytoplasmic domain and
Ca2+–calmodulin, Front. Mol. Neurosci. 5 (2012).
[51] J.P. Berlose, O. Convert, D. Derossi, A. Brunissen, G. Chassaing, Conformational
and associative behaviours of the third helix of antennapedia homeodomain in
membrane-mimetic environments, Eur. J. Biochem. 242 (1996) 372–386.
[52] J.J. Chou, J.D. Kaufman, S.J. Stahl, P.T.Wingﬁeld, A. Bax,Micelle-induced curvature in
a water-insoluble HIV-1 Env peptide revealed by NMR dipolar coupling measure-
ment in stretched polyacrylamide gel, J. Am. Chem. Soc. 124 (2002) 2450–2451.
[53] E.J. Dufourc, I.C.P. Smith, J. Dufourcq, Molecular details of melittin-induced lysis
of phospholipid membranes as revealed by deuterium and phosphorus NMR,
Biochemistry 25 (1986) 6448–6455.
[54] M. Ouellet, N. Voyer, M. Auger, Membrane interactions and dynamics of a 21-mer
cytotoxic peptide: a solid-state NMR study, Biochim. Biophys. Acta 1798 (2010)
235–243.
[55] Y. Su, M. Hong, Conformational disorder of membrane peptides investigated
from solid-state NMR line widths and line shapes, J. Phys. Chem. B 115 (2011)
10758–10767.
[56] X. Yu, S. Chu, A.E. Hagerman, G.A. Lorigan, Probing the interaction of polyphe-
nols with lipid bilayers by solid-state NMR spectroscopy, J. Agr. Food Chem. 59
(2011) 6783–6789.
[57] G.P. Holland, S.K. McIntyre, T.M. Alam, Distinguishing individual lipid headgroup
mobility and phase transitions in raft-forming lipid mixtures with 31P MAS
NMR, Biophys. J. 90 (2006) 4248–4260.
[58] S. Abu-Baker, G.A. Lorigan, Phospholamban and its phosphorylated form interact
differently with lipid bilayers: a 31P, 2H, and 13C solid-state NMR spectroscopic
study, Biochemistry 45 (2006) 13312–13322.
[59] S. Abu-Baker, X. Qi, G.A. Lorigan, Investigating the interaction of saposin s with
POPS and POPC phospholipids: a solid-state NMR spectroscopic study, Biophys.
J. 93 (2007) 3480–3490.
[60] N. Bloembergen, Proton relaxation times in paramagnetic solutions, J. Chem.
Phys. 27 (1957) 572–573.
[61] I. Solomon, Relaxation processes in a systemof two spins, Phys. Rev. 99 (1955) 559.
[62] V.V. Kumar, W.J. Baumann, Lanthanide-induced phosphorus-31 NMR downﬁeld
chemical shifts of lysophosphatidylcholines are sensitive to lysophospholipid
critical micelle concentration, Biophys. J. 59 (1991) 103–107.
[63] V.V. Kumar, B. Malewicz, W.J. Baumann, Lysophosphatidylcholine stabilizes
small unilamellar phosphatidylcholine vesicles. Phosphorus-31 NMR evidence
for the “wedge” effect, Biophys. J. 55 (1989) 789–792.
[64] C.P. Jaroniec, Solid-state nuclear magnetic resonance structural studies of pro-
teins using paramagnetic probes, Solid State Nucl. Mag. 43–44 (2012) 1–13.
[65] P. Nadaud, I. Sengupta, J. Helmus, C. Jaroniec, Evaluation of the inﬂuence of
intermolecular electron-nucleus couplings and intrinsic metal binding sites on
the measurement of 15N longitudinal paramagnetic relaxation enhancements
in proteins by solid-state NMR, J. Biomol. NMR 51 (2011) 293–302.
[66] P.S. Nadaud, J.J. Helmus, S.L. Kall, C.P. Jaroniec, Paramagnetic ions enable tuning
of nuclear relaxation rates and provide long-range structural restraints in
solid-state NMR of proteins, J. Am. Chem. Soc. 131 (2009) 8108–8120.
[67] P.S. Nadaud, J.J. Helmus, I. Sengupta, C.P. Jaroniec, Rapid acquisition of
multidimensional solid-state NMR spectra of proteins facilitated by covalently
bound paramagnetic tags, J. Am. Chem. Soc. 132 (2010) 9561–9563.
[68] I. Sengupta, P.S. Nadaud, J.J. Helmus, C.D. Schwieters, C.P. Jaroniec, Protein fold
determined by paramagnetic magic-angle spinning solid-state NMR spectrosco-
py, Nat. Chem. 4 (2012) 410–417.
[69] S. Parthasarathy, F. Long, Y. Miller, Y. Xiao, D. McElheny, K. Thurber, B. Ma, R.
Nussinov, Y. Ishii, Molecular-level examination of Cu2+ binding structure for
amyloid ﬁbrils of 40-residue Alzheimer's β by solid-state NMR spectroscopy,
J. Am. Chem. Soc. 133 (2011) 3390–3400.
[70] K. Yamamoto, J. Xu, K.E. Kawulka, J.C. Vederas, A. Ramamoorthy, Use of a
copper-chelated lipid speeds up NMR measurements from membrane proteins,
J. Am. Chem. Soc. 132 (2010) 6929–6931.
[71] J. Iwahara, D.E. Anderson, E.C. Murphy, G.M. Clore, EDTA-derivatized
deoxythymidine as a tool for rapid determination of protein binding polarity
to DNA by intermolecular paramagnetic relaxation enhancement, J. Am. Chem.
Soc. 125 (2003) 6634–6635.
[72] J. Iwahara, G.M. Clore, Detecting transient intermediates in macromolecular
binding by paramagnetic NMR, Nature 440 (2006) 1227–1230.
[73] S.H. Park, C. Loudet, F.M. Marassi, E.J. Dufourc, S.J. Opella, Solid-state NMR
spectroscopy of a membrane protein in biphenyl phospholipid bicelles with
the bilayer normal parallel to the magnetic ﬁeld, J. Magn. Reson. 193 (2008)
133–138.
[74] S. Chu, S. Maltsev, A.H. Emwas, G.A. Lorigan, Solid-state NMR paramagnetic
relaxation enhancement immersion depth studies in phospholipid bilayers,
J. Magn. Reson. 207 (2010) 89–94.
[75] P.R. Cullis, M.B. Bally, T.D. Madden, L.D. Mayer, M.J. Hope, pH gradients and mem-
brane transport in liposomal systems, Trends Biotechnol. 9 (1991) 268–272.
[76] D. Terrone, S.L.W. Sang, L. Roudaia, J.R. Silvius, Penetratin and related
cell-penetrating cationic peptides can translocate across lipid bilayers in the
presence of a transbilayer potential, Biochemistry 42 (2003) 13787–13799.
[77] D.W. Deamer, R.C. Prince, A.R. Crofts, The response ofﬂuorescent amines to pH gra-
dients across liposome membranes, Biochim. Biophys. Acta 274 (1972) 323–335.
1682 L.E. Marbella et al. / Biochimica et Biophysica Acta 1828 (2013) 1674–1682[78] M. Traikia, D.E. Warschawski, M. Recouvreur, J. Cartaud, P.F. Devaux, Formation
of unilamellar vesicles by repetitive freeze-thaw cycles: characterization by
electron microscopy and P-31-nuclear magnetic resonance, Eur. Biophys. J.
Biophys. Lett. 29 (2000) 184–195.
[79] S. Deshayes, M.C. Morris, G. Divita, F. Heitz, Cell-penetrating peptides: tools for
intracellular delivery of therapeutics, Cell. Mol. Life Sci. 62 (2005) 1839–1849.
[80] M. Hansen, K. Kilk, Ü. Langel, Predicting cell-penetrating peptides, Adv. Drug
Deliv. Rev. 60 (2008) 572–579.
[81] M. Zorko, Ü. Langel, Cell-penetrating peptides: mechanism and kinetics of cargo
delivery, Adv. Drug Deliv. Rev. 57 (2005) 529–545.
[82] C.M. Deber, B.A. Behnam, Role of membrane lipids in peptide hormone function:
binding of enkephalins to micelles, Proc. Natl. Acad. Sci. 81 (1984) 61–65.
[83] C.R. Sanders, G.C. Landis, Facile acquisition and assignment of oriented sample
NMR spectra for bilayer surface-associated proteins, J. Am. Chem. Soc. 116
(1994) 6470–6471.
[84] C.R. Sanders, G.C. Landis, Reconstitution of membrane proteins into lipid-rich
bilayered mixed micelles for NMR studies, Biochemistry 34 (1995) 4030–4040.
[85] D. Persson, P.E.G. Thorén, E.K. Esbjörner, M. Goksör, P. Lincoln, B. Nordén, Vesicle
size-dependent translocation of penetratin analogs across lipid membranes, BBA
- Biomembranes 1665 (2004) 142–155.
[86] N. Khalifat, N. Puff, S. Bonneau, J.-B. Fournier, M.I. Angelova, Membrane defor-
mation under local pH gradient: mimicking mitochondrial cristae dynamics,
Biophys. J. 95 (2008) 4924–4933.
[87] N. Tomsie, B. Babnik, D. Lombardo, B. Mavcic, M. Kandušer, A. Iglic, V. Kralj-Iglic,
Shape and size of giant unilamellar phospholipid vesicles containing cardiolipin,
J. Chem. Info. Mod. 45 (2005) 1676–1679.
[88] C. Schwieger, A. Blume, Interaction of Poly(L-arginine) with negatively charged
dppg membranes: calorimetric and monolayer studies, Biomacromolecules 10
(2009) 2152–2161.
[89] M.E. Herbig, U. Fromm, J. Leuenberger, U. Krauss, A.G. Beck-Sickinger, H.P. Merkle,
Bilayer interaction and localization of cell penetrating peptides with model mem-
branes: a comparative study of a human calcitonin (hCT)-derived peptide with
pVEC and pAntp(43–58), Biochim. Biophys. Acta-Biomembr. 1712 (2005) 197–211.
[90] S. Kawamoto, M. Takasu, T. Miyakawa, R. Morikawa, T. Oda, S. Futaki, H. Nagao,
Binding of Tat peptides on DOPC and DOPG lipid bilayer membrane studied by
molecular dynamics simulations, Mol. Simul. 38 (2012) 366–368.
[91] M.F. Lensink, B. Christiaens, J. Vandekerckhove, A. Prochiantz, M. Rosseneu,
Penetratin-membrane association: W48/R52/W56 shield the peptide from the
aqueous phase, Biophys. J. 88 (2005) 939–952.[92] M. Magzoub, L.E.G. Eriksson, A. Graslund, Conformational states of the
cell-penetrating peptide penetratin when interacting with phospholipid vesi-
cles: effects of surface charge and peptide concentration, Biochim. Biophys.
Acta-Biomembr. 1563 (2002) 53–63.
[93] M. Magzoub, K. Kilk, L.E.G. Eriksson, U. Langel, A. Graslund, Interaction and
structure induction of cell-penetrating peptides in the presence of phospholipid
vesicles, BBA — Biomembranes 1512 (2001) 77–89.
[94] Y. Takechi, H. Tanaka, H. Kitayama, H. Yoshii, M. Tanaka, H. Saito, Comparative
study on the interaction of cell-penetrating polycationic polymers with lipid
membranes, Chem. Phys. Lipids 165 (2012) 51–58.
[95] A. Ziegler, X.L. Blatter, A. Seelig, J. Seelig, Protein transduction domains of HIV-1
and SIV TAT interact with charged lipid vesicles, Binding Mechanism and
Thermodynamic Analysis, Biochemistry 42 (2003) 9185–9194.
[96] J. Bjorklund, H. Biverstahl, A. Graslund, L. Maler, P. Brzezinski, Real-time trans-
membrane translocation of penetratin driven by light-generated proton
pumping, Biophys. J. 91 (2006) L29–L31.
[97] H.D. Herce, A.E. Garcia, J. Litt, R.S. Kane, P. Martin, N. Enrique, A. Rebolledo, V.
Milesi, Arginine-rich peptides destabilize the plasma membrane, consistent
with a pore formation translocation mechanism of cell-penetrating peptides,
Biophys. J. 97 (2009) 1917–1925.
[98] M. Magzoub, A. Pramanik, A. Graslund, Modeling the endosomal escape of
cell-penetrating peptides: transmembrane pH gradient driven translocation
across phospholipid bilayers, Biochemistry 44 (2005) 14890–14897.
[99] K. Hristova, S.H. White, An experiment-based algorithm for predicting the
partitioning of unfolded peptides into phosphatidylcholine bilayer interfaces,
Biochemistry 44 (2005) 12614–12619.
[100] W. Wimley, S. White, Experimentally determined hydrophobicity scale for pro-
teins at membrane interfaces, Nat. Struct. Mol. Biol. 3 (1996) 842–848.
[101] W.C. Wimley, T.P. Creamer, S.H. White, Solvation energies of amino acid side
chains and backbone in a family of host–guest pentapeptides, Biochemistry 35
(1996) 5109–5124.
[102] K. Zhao, G.-M. Zhao, D. Wu, Y. Soong, A.V. Birk, P.W. Schiller, H.H. Szeto,
Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane
inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury,
J. Biol. Chem. 279 (2004) 34682–34690.
[103] S.B. Fonseca, M.P. Pereira, R. Mourtada, M. Gronda, K.L. Horton, R. Hurren, M.D.
Minden, A.D. Schimmer, S.O. Kelley, Rerouting chlorambucil to mitochondria
combats drug deactivation and resistance in cancer cells, Chem. Biol. 18 (2011)
445–453.
